Invention Grant
![2-hetaryl imidazol[1,2-a]pyridine derivatives](/docs/US/2022-06-14/US11358962B2/abs.jpg.600x600.jpg)
- Patent Title: 2-hetaryl imidazol[1,2-a]pyridine derivatives
-
Application No.: US16161299Application Date: 2018-10-16
-
Publication No.: US11358962B2Publication Date: 2022-06-14
- Inventor: Edilio Borroni , Luca Gobbi , Michael Honer , Henner Knust , Matthias Koerner , Dieter Muri
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: Hoffmann-La Roche Inc.
- Current Assignee: Hoffmann-La Roche Inc.
- Current Assignee Address: US NJ Little Falls
- Agency: Genentech, Inc.
- Agent Richard G. A. Bone
- Priority: EP13165676 20130429
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K49/00
![2-hetaryl imidazol[1,2-a]pyridine derivatives](/abs-image/US/2022/06/14/US11358962B2/abs.jpg.150x150.jpg)
Abstract:
The invention relates to small molecule imaging tools, specifically compounds of formula II and to pharmaceutically acceptable acid addition salts thereof, wherein R1-R6 have any of the values defined in the specification.
Public/Granted literature
- US20190048002A1 2-PHENYL OR 2-HETARYL IMIDAZOL[1,2-a]PYRIDINE DERIVATIVES Public/Granted day:2019-02-14
Information query
